Kirsten Kay Arrendale, APRN

Kirsten Arrendale practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Kirsten Arrendale's NPI, 1528709813, was assigned on April 2, 2022. Kirsten Arrendale holds Florida license APRN11017953.

Kirsten Arrendale's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Kirsten Arrendale's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Kirsten Arrendale to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kirsten Arrendale practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Kirsten Arrendale's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Kirsten Arrendale is licensed in Florida.

CMS counts 104 Medicare patients who saw Kirsten Arrendale in 2024. The largest group is 65 to 74, with 65 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kirsten Arrendale's median patient age at 70, with 49% women.

In 2024, Kirsten Arrendale wrote 24 Medicare Part D claims for 11 patients. 88% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Kirsten Arrendale for performance year 2024, reported as part of a group. Kirsten Arrendale accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Kirsten Arrendale from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Legend Biotech USA Inc. paid the most, $23.